STOCK TITAN

AMDOCS LTD SEC Filings

DOX NASDAQ

Welcome to our dedicated page for AMDOCS SEC filings (Ticker: DOX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

Amdocs Limited SEC filings document the disclosures of a foreign private issuer that provides software and services to communications and media companies. Its Form 6-K reports include quarterly and annual financial materials, consolidated financial statements, operating and financial review, earnings presentations, and disclosures on equity activity and issuer purchases.

The filing record also covers shareholder meeting materials and voting results, including board elections, employee share purchase plan amendments, dividend program approvals, auditor ratification, and governance changes involving executive leadership and board composition. Registration-statement incorporation language connects selected Form 6-K reports to Amdocs' equity compensation filings on Form S-8.

Rhea-AI Summary

AMDOCS LTD director Genish Amos filed an initial ownership report showing his equity position in the company. The filing reports direct ownership of 11,353 Ordinary Shares, including shares subject to outstanding restricted stock units. This Form 3 does not disclose any buy or sell transactions; it simply establishes his current holdings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Amdocs Ltd director Gelman Eliahu Meir filed an initial ownership report showing a substantial equity stake in the company. The Form 3 lists direct beneficial ownership of 340,136 Ordinary Shares. A footnote explains that this figure includes Ordinary Shares subject to outstanding restricted stock awards, so the total reflects both vested and unvested equity-based compensation rather than a recent market transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Amdocs Ltd director Veronique Morali reported her initial holdings of company equity in a Form 3. The filing shows she beneficially owns 4,405 Ordinary Shares, which are represented by shares of Class A Common Stock subject to outstanding restricted stock units. This reflects her existing equity-based compensation position rather than a new market transaction.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Amdocs Ltd officer Matthew E. Smith filed an initial ownership report showing a mix of stock options and ordinary shares. He holds options over 2,683 Ordinary Shares at an exercise price of 55.8800 expiring on February 1, 2029, 3,127 shares at 71.9500 expiring on February 1, 2030, and 925 shares at 67.4600 expiring on June 1, 2028. The filing also lists 2,014 Ordinary Shares held directly, including shares subject to outstanding restricted stock awards. The options vest in equal annual installments over four years from their grant dates.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Amdocs Ltd director John Anthony MacDonald filed an initial ownership report showing direct beneficial ownership of 24,189 Ordinary Shares. This total includes Ordinary Shares subject to outstanding restricted stock units, reflecting both currently held shares and equity awards that may vest in the future.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Amdocs Ltd director Robert A. Minicucci has filed an initial ownership report showing his equity stake in the company. The filing lists direct ownership of 304,673 Ordinary Shares and an additional 1,088 Ordinary Shares held indirectly by his spouse. The direct holdings include Ordinary Shares that are subject to outstanding restricted stock awards, indicating a mix of fully vested and restricted equity exposure.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Amdocs Ltd officer Rajat Raheja has filed an initial Form 3 reporting existing equity awards. The filing lists multiple Restricted Stock Unit (RSU) grants tied to Ordinary Shares, with individual awards covering 360, 748, 746, 1,050, 1,399 and 1,560 underlying shares. These RSUs vest on various schedules between Nov 10, 2026 and Nov 14, 2029, and each RSU represents a contingent right to receive one Ordinary Share.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Amdocs Limited reported modest growth for the quarter ended December 31, 2025, with revenue rising 4.1% to $1,155.9 million and operating income up 3.9% to $206.7 million, sustaining a 17.9% operating margin. Net income attributable to Amdocs increased 4.3% to $157.6 million, and diluted earnings per share improved to $1.45 from $1.33, helped by share repurchases reducing the share count.

Managed services remained the core of the business, generating $745.9 million of revenue, while North America contributed 66.2% of total sales, Europe 15.7%, and the rest of the world 18.1%. Operating cash flow jumped to $220.2 million, yielding free cash flow of $188.0 million after $32.2 million of capital expenditures.

The company deployed significant capital: it acquired Matrixx Software for approximately $197 million in cash, repurchased about 1.8 million shares for $146.2 million at an average price of $79.78, and paid $56.7 million in dividends at $0.527 per share. Shareholders later approved an 8% quarterly dividend increase to $0.569 per share, while Amdocs ended the quarter with $247.9 million in cash, $130.0 million drawn on its $500.0 million revolving credit facility, and $650.0 million in Senior Notes outstanding.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
current report
-
Rhea-AI Summary

FMR LLC and Abigail P. Johnson report beneficial ownership of Amdocs Limited common stock. They disclose beneficial ownership of 12,093,177.13 shares, representing 11.2% of the outstanding common stock as of the event date. FMR LLC has sole voting power over 9,918,389.29 shares and sole dispositive power over 12,093,177.13 shares, while Abigail P. Johnson has sole dispositive power over the same 12,093,177.13 shares but no voting power. The securities are certified as acquired and held in the ordinary course of business and not for the purpose of changing or influencing control of Amdocs Limited.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
Rhea-AI Summary

Amdocs Limited announced a planned leadership transition, with longtime executive Shuky Sheffer retiring as President and CEO of Amdocs Management Limited and being succeeded by Shimie Hortig, currently Group President of the Americas Business Group, effective March 31, 2026. The board highlighted Sheffer’s role in steering Amdocs through the pandemic and technology shifts, including its move to cloud-native, AI-enabled offerings. Hortig brings more than two decades of experience at Amdocs across senior corporate, finance, and business leadership roles, including leading its largest Americas region. Amdocs, a NASDAQ-listed provider of software and services to communications and media companies, reported revenue of $4.53 billion in fiscal 2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.3%
Tags
current report

FAQ

How many AMDOCS (DOX) SEC filings are available on StockTitan?

StockTitan tracks 40 SEC filings for AMDOCS (DOX), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for AMDOCS (DOX)?

The most recent SEC filing for AMDOCS (DOX) was filed on March 18, 2026.